As an endocrinologist board-certified in diabetes, lipidology, hypertension and obesity, practicing in Montgomery County, Maryland, one of my objectives is to employ a holistic approach in diagnosing and managing metabolic syndrome. Frequently, my patients inquire about the definition, significance, and available therapeutic options for metabolic syndrome. Without delay, let’s explore the details of what metabolic syndrome involves.
Metabolic Syndrome (also known as Syndrome X, Insulin Resistance Syndrome, or Dysmetabolic Syndrome)
It is a cluster of conditions that occur together, increasing the risk of heart disease, NASH, and type 2 diabetes, among others. The precise medical definition and diagnostic criteria may vary slightly among different organizations, but a widely accepted definition is provided by the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III).
The NCEP-ATP III criteria for metabolic syndrome include the presence of three or more of the following five factors:
- Central Obesity: Defined by an increased waist circumference. A waist circumference of 40 inches (102 centimeters) or greater in men and 35 inches (88 centimeters) or greater in women is indicative of central obesity.
- Elevated Blood Pressure: Blood pressure equal to or greater than 130/85 mmHg or the use of antihypertensive medications.
- Elevated Fasting Blood Glucose: Fasting glucose levels equal to or greater than 100 mg/dL or the use of medications for elevated glucose.
- Elevated Triglycerides: Serum triglyceride levels equal to or greater than 150 mg/dL.
- Reduced High-Density Lipoprotein (HDL) Cholesterol: HDL cholesterol levels less than 40 mg/dL in men or less than 50 mg/dL in women.
It is important to note that metabolic syndrome is associated with insulin resistance, a condition where the body’s cells do not respond effectively to insulin, leading to high levels of insulin in the blood. This underlying insulin resistance is thought to be a central factor in the development of metabolic syndrome.
Consequences of Metabolic Syndrome
- Heart Disease: Metabolic syndrome poses a serious threat to overall health, with a range of severe consequences. One notable concern is the heightened risk of cardiovascular diseases. Individuals afflicted with metabolic syndrome face an elevated likelihood of developing heart-related conditions such as heart attacks and strokes. This increased risk is attributed to factors like high blood pressure, elevated triglyceride levels, and insulin resistance, all of which contribute to the strain on the cardiovascular system.
- Type 2 Diabetes: Moreover, the syndrome is closely linked to the development of type 2 diabetes. Insulin resistance and elevated blood sugar levels, characteristic components of metabolic syndrome, significantly escalate the risk of progressing to diabetes. This interconnection underscores the importance of managing metabolic syndrome to prevent the onset of this chronic metabolic disorder.
- Non-alcoholic fatty liver disease (NAFLD): Liver diseases, particularly NAFLD, are also more prevalent in individuals with metabolic syndrome. NAFLD involves the accumulation of fat in the liver, leading to inflammation and scarring. This underscores the multisystem impact of metabolic syndrome, affecting not only the cardiovascular and metabolic systems but also the liver.
- Kidney Disease: Additionally, metabolic syndrome raises the risk of kidney disease. Individuals with this syndrome face an increased likelihood of developing chronic kidney disease, emphasizing the pervasive nature of its consequences on various vital organs.
- Sleep Apnea: Sleep apnea is another health concern associated with metabolic syndrome. The syndrome’s presence is linked to an elevated risk of sleep apnea, a condition characterized by interrupted breathing during sleep. This underscores the broad impact of metabolic syndrome on different physiological functions, including those related to sleep and respiratory health.
- Mortality Increase: Perhaps most concerning is the overall increase in mortality associated with metabolic syndrome. The combination of risk factors such as cardiovascular issues, diabetes, liver diseases, kidney problems, and sleep apnea significantly amplifies the overall risk of premature death. Consequently, addressing metabolic syndrome through lifestyle modifications and medical interventions is essential to mitigate these potentially life-threatening consequences.
Brief Approach to Metabolic Syndrome
Addressing metabolic syndrome often involves lifestyle changes such as adopting a healthy diet, increasing physical activity, and, in some cases, medications to manage specific components like insulin resistance, blood pressure or cholesterol levels. Early detection and intervention are key to preventing the complications associated with metabolic syndrome.

References:
- Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Fahed G, Aoun L, Bou Zerdan M, et al. International Journal of Molecular Sciences. 2022;23(2):786. doi:10.3390/ijms23020786.
- Metabolic Syndrome. Neeland IJ, Lim S, Tchernof A, et al. Nature Reviews. Disease Primers. 2024;10(1):77. doi:10.1038/s41572-024-00563-5.
- Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Meschia JF, Bushnell C, Boden-Albala B, et al. Stroke. 2014;45(12):3754-832. doi:10.1161/STR.0000000000000046.
- The Metabolic Syndrome – What Is It and How Should It Be Managed?. Nilsson PM, Tuomilehto J, Rydén L. European Journal of Preventive Cardiology. 2019;26(2_suppl):33-46. doi:10.1177/2047487319886404.
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Whelton PK, Carey RM, Aronow WS, et al. Circulation. 2018;138(17):e484-e594. doi:10.1161/CIR.0000000000000596.
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Grundy SM, Stone NJ, Bailey AL, et al. Journal of the American College of Cardiology. 2019;73(24):e285-e350. doi:10.1016/j.jacc.2018.11.003.
- The Metabolic Syndrome. Cornier MA, Dabelea D, Hernandez TL, et al. Endocrine Reviews. 2008;29(7):777-822. doi:10.1210/er.2008-0024.
- Nutrients, Physical Activity, and Mitochondrial Dysfunction in the Setting of Metabolic Syndrome. Lemos GO, Torrinhas RS, Waitzberg DL. Nutrients. 2023;15(5):1217. doi:10.3390/nu15051217.
- Metabolic Syndrome Pathophysiology and Predisposing Factors. Bovolini A, Garcia J, Andrade MA, Duarte JA. International Journal of Sports Medicine. 2021;42(3):199-214. doi:10.1055/a-1263-0898.
- New Advances in Metabolic Syndrome, From Prevention to Treatment: The Role of Diet and Food. Ambroselli D, Masciulli F, Romano E, et al. Nutrients. 2023;15(3):640. doi:10.3390/nu15030640.
About Dr. Gerti Tashko, MD
Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.



